ZEESHAN HAQ
Ophthalmology Physician · EDINA, MN
Individual Active NPI 1396278438
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 722 | 35,315 | $11,651,518 | $3,263,596 | $2,569,475 |
| 2023 | 463 | 8,714 | $3,160,595 | $911,382 | $723,901 |
| 2022 | 54 | 172 | $57,209 | $18,479 | $14,367 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 26,520 | $34 | $27 |
| 92134 | Imaging of retina | 2,025 | $42 | $30 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,712 | $332 | $265 |
| 67028 | Injection of drug into eye | 1,350 | $130 | $96 |
| J0178 | Injection, aflibercept, 1 mg | 1,188 | $829 | $659 |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 969 | $235 | $186 |
| 92012 | Established patient problem focused exam of visual system | 534 | $93 | $65 |
| 92014 | Established patient complete exam of visual system | 211 | $131 | $91 |
| J9035 | Injection, bevacizumab, 10 mg | 163 | $72 | $55 |
| J2778 | Injection, ranibizumab, 0.1 mg | 155 | $160 | $126 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 97 | $170 | $126 |
| 92004 | New patient complete exam of visual system | 85 | $152 | $101 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 68832 | MN |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | 68832 | MN |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Minnesota
- NPI 1093032435
- NPI 1093456303
- NPI 1497508642
- NPI 1609005487
- NPI 1336360593
- NPI 1366418790
- NPI 1386612364
- NPI 1942941935
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.